Jacob Sarah I, Murray Kevin J, Rendahl Aaron K, Geor Raymond J, Schultz Nichol E, McCue Molly E
Michigan State University College of Veterinary Medicine, Large Animal Clinical Sciences, East Lansing, Michigan.
University of Minnesota College of Veterinary Medicine, Veterinary Population Medicine, St. Paul, Minnesota.
J Vet Intern Med. 2018 May;32(3):1215-1233. doi: 10.1111/jvim.15095. Epub 2018 Mar 23.
Metabolomics, the study of small-molecule metabolites, has increased understanding of human metabolic diseases, but has not been used to study equine metabolic syndrome (EMS).
(1) To examine the serum metabolome of Welsh Ponies with and without insulin dysregulation before and during an oral sugar test (OST). (2) To identify differences in metabolites in ponies with insulin dysregulation, obesity, or history of laminitis.
Twenty Welsh Ponies (mean ± SD; 13.8 ± 9.0 years) classified as non-insulin dysregulated [CON] (n = 10, insulin < 30 mU/L) or insulin dysregulated [ID] (n = 10, insulin > 60 mU/L) at 75 minutes after administration of Karo syrup, obese (n = 6) or nonobese (n = 14), and history of laminitis (n = 9) or no history of laminitis (n = 11).
Case-control study. Metabolomic analysis was performed on serum obtained at 0 minutes (baseline) and 75 minutes during the OST. Data were analyzed with multivariable mixed linear models with significance set at P ≤ .05.
Metabolomic analysis of 646 metabolites (506 known) detected significant metabolite differences. At baseline, 55 metabolites (insulin response), 91 metabolites (obesity status), and 136 metabolites (laminitis history) were different. At 75 minutes, 51 metabolites (insulin response), 102 metabolites (obesity status), and 124 metabolites (laminitis history) were different.
Use of metabolomics could have diagnostic utility for early detection of EMS and provide new knowledge regarding the pathophysiology of metabolic perturbations associated with this condition that might lead to improved clinical management.
代谢组学是对小分子代谢物的研究,它增进了我们对人类代谢疾病的了解,但尚未用于研究马代谢综合征(EMS)。
(1)检查在口服糖耐量试验(OST)之前和期间,胰岛素调节异常和胰岛素调节正常的威尔士矮种马的血清代谢组。(2)确定胰岛素调节异常、肥胖或有蹄叶炎病史的矮种马体内代谢物的差异。
20匹威尔士矮种马(平均±标准差;13.8±9.0岁),分为非胰岛素调节异常组[CON](n = 10,胰岛素<30 mU/L)或胰岛素调节异常组[ID](n = 10,胰岛素>60 mU/L),在服用卡罗糖浆75分钟后,肥胖组(n = 6)或非肥胖组(n = 14),有蹄叶炎病史组(n = 9)或无蹄叶炎病史组(n = 11)。
病例对照研究。对在OST期间0分钟(基线)和75分钟采集的血清进行代谢组学分析。数据采用多变量混合线性模型进行分析,显著性设定为P≤0.05。
对646种代谢物(506种已知)的代谢组学分析检测到显著的代谢物差异。在基线时,55种代谢物(胰岛素反应)、91种代谢物(肥胖状态)和136种代谢物(蹄叶炎病史)存在差异。在75分钟时,51种代谢物(胰岛素反应)、102种代谢物(肥胖状态)和124种代谢物(蹄叶炎病史)存在差异。
代谢组学的应用可能对早期检测EMS具有诊断价值,并为与该病症相关的代谢紊乱的病理生理学提供新知识,这可能有助于改善临床管理。